Furthermore, researchers have utilized ALKBH5 to develop risk assessment models, which divide lung adenocarcinoma (LUAD) patients into high-risk and low-risk categories on the basis of the constructed models, emphasizing the potential of ALKBH5 as a marker for cancer prognosis (35, 36). The gene discussed is ALKBH5; the disease is lung adenocarcinoma.